| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA696421 | F | Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP) | 44 | cell-free format | Scientific Literature | |||
| 2. | ALA696422 | F | Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma PRP | 30 | cell-free format | Scientific Literature | |||
| 3. | ALA696574 | F | Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma PRP; Not tested | 1 | cell-free format | Scientific Literature | |||
| 4. | ALA756288 | F | The compound was evaluated for antagonist activity against phospholipase C coupled human P2Y purinoceptor 12 (P2Y12) | 1 | assay format | Scientific Literature | |||
| 5. | ALA756290 | F | The compound was evaluated for antagonist activity against platelet P2Y purinoceptor 12 (P2Y12) | 1 | assay format | Scientific Literature | |||
| 6. | ALA766760 | B | Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12 | 15 | tissue-based format | Scientific Literature | |||
| 7. | ALA766761 | B | Compound was evaluated for its ability to inhibit human Purinergic receptor P2Y12 expressed in Xenopus oocyte | 1 | tissue-based format | Scientific Literature | |||
| 8. | ALA766762 | B | Binding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligand | 2 | tissue-based format | Scientific Literature | |||
| 9. | ALA767230 | F | Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP) | 76 | cell-free format | Scientific Literature | |||
| 10. | ALA842944 | F | In vitro inhibitory activity against ADP-induced human platelet aggregation | 42 | assay format | Scientific Literature | |||
| 11. | ALA863371 | B | Binding affinity to P2Y12 receptor expressed in human platelets from 0.047 to 50 nM | Homo sapiens | 1 | assay format | Scientific Literature | ||
| 12. | ALA923908 | F | Antagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregation | Homo sapiens | 3 | assay format | Scientific Literature | ||
| 13. | ALA923909 | B | Displacement of [125I] labeled ligand from human P2Y12 receptor in human platelets | Homo sapiens | 14 | assay format | Scientific Literature | ||
| 14. | ALA933022 | F | Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay | 22 | assay format | Scientific Literature | |||
| 15. | ALA933023 | F | Antagonist activity at P2Y12 receptor assessed as platelet aggregation at 30 uM by washed platelet assay | 15 | assay format | Scientific Literature | |||
| 16. | ALA931130 | F | Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay | Homo sapiens | 36 | assay format | Scientific Literature | ||
| 17. | ALA931131 | F | Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay at 100 uM | Homo sapiens | 16 | assay format | Scientific Literature | ||
| 18. | ALA932177 | F | Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation in whole blood | Homo sapiens | 1 | tissue-based format | Scientific Literature | ||
| 19. | ALA932178 | F | Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation in platelet-rich plasma | Homo sapiens | 1 | cell-free format | Scientific Literature | ||
| 20. | ALA932179 | F | Antagonist activity at P2Y12 receptor assessed as inhibition of 2-MeS-ADP-induced human platelet aggregation | Homo sapiens | 1 | assay format | Scientific Literature |
The page will load shortly, Thanks for your patience!